Drugs for HER-2-positive Breast Cancer (Milestones in Drug Therapy)

by Maria Sibilia (Editor), Christoph C . Zielinski (Editor), ThomasW.Grunt (Editor), RupertBartsch (Editor)

New
Hardcover
2011
$222.00

Growth factor receptors have long been known to drive malignant transformation and cancer progression. The epidermal growth factor receptor (EGFR, ErbB, HER) system is likely the best described membrane receptor tyrosine kinase family in malignant tumors.

Synopsis

Growth factor receptors have long been known to drive malignant transformation and cancer progression. The epidermal growth factor receptor (EGFR, ErbB, HER) system is likely the best described membrane receptor tyrosine kinase family in malignant tumors.

$222.00

Quantity

20+ in stock

More Information

Format: Hardcover
Pages: 119
Edition: 1st Edition.
Publisher: Springer Basel
Published: 07 Jan 2011
ISBN 10: 3034600933
ISBN 13: 9783034600934

Drugs for HER-2-positive Breast Cancer (Milestones in Drug Therapy)

New

$222.00

Synopsis

$222.00

More Information